Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Biocapital, L.p. Samsara

10% Owner at Kalaris Therapeutics, Inc. (KLRS)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-16.3%
vs. S&P 500-18.8%
Beat the market0%
Paper profit on buys−$603K
Total bought / sold$1.2M / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 22SEC KLRSKalaris Therapeutics, Inc. Buy 244,3002,224,147 held (+12%) $4.83 $1.2M -51.1%
  • Buy

    10% Owner Biocapital, L.p. Samsara bought $1.2M of KLRS at $4.83 — first open-market purchase in our records.